Stockscreener 앱 받기
12.88
1.02%
0.13
시간 외 거래:
12.89
0.010
+0.08%
Bioage Labs Inc 주식(BIOA)의 최신 뉴스
Morgan Stanley Upgrades BioAge Labs (BIOA) - Nasdaq
BioAge Labs (BIOA) Competitors and Alternatives 2025 - MarketBeat
Volume Recap: How BioAge Labs Inc stock reacts to Fed rate cutsFed Meeting & Technical Pattern Recognition Alerts - BỘ NỘI VỤ
BioAge Labs CMO Paul D. Rubin Sells All Common Stock Holdings - TradingView
Officer Rubin Sells 68,897 ($701.9K) Of BioAge Labs Inc [BIOA] - TradingView
BioAge Labs stock rating upgraded by Morgan Stanley on promising BGE-102 data - Investing.com South Africa
How BioAge Labs Inc. stock reacts to Fed rate cutsShort Setup & Fast Gain Stock Trading Tips - Newser
BioAge’s NLRP3 inhibitor shows positive Phase 1 data in clinical trial - Investing.com Nigeria
Is BioAge Labs Inc. stock a safe haven assetQuarterly Earnings Summary & Safe Entry Zone Identification - Newser
Why BioAge Labs Inc. stock remains undervaluedCEO Change & Smart Money Movement Alerts - Newser
How BioAge Labs Inc. (Y7G) stock stacks up against competitorsInsider Selling & Daily Chart Pattern Signal Reports - Newser
Positive Developments and Promising Trials Bolster Buy Rating for BioAge Labs - TipRanks
Citi Maintains BioAge Labs(BIOA.US) With Buy Rating, Maintains Target Price $15 - 富途牛牛
Officer Rubin Files To Sell 68,897 Of BioAge Labs Inc [BIOA] - TradingView
Will BioAge Labs Inc. (Y7G) stock outperform global peersCEO Change & Safe Capital Investment Plans - Newser
Merger Talk: Is BioAge Labs Inc stock a safe haven assetPortfolio Growth Summary & Weekly Watchlist of Top Performers - BỘ NỘI VỤ
BioAge Labs BGE-102 Phase 1 Trial Shows Potential in Targeting Inflammation in Central Nervous System, Peripheral Tissues - marketscreener.com
BioAge Reports Positive Interim Phase 1 Data For BGE-102; Shares Rise - Nasdaq
BioAge Labs Announces Positive Phase 1 Trial Results - TipRanks
BioAge Announces Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor - markets.businessinsider.com
BioAge Labs, Inc. Announces Positive Interim Phase 1 Data for BGE-102 - TradingView
BioAge’s NLRP3 inhibitor shows positive Phase 1 data in clinical trial By Investing.com - Investing.com South Africa
Is BioAge Labs Inc. (Y7G) stock a buy before new product rolloutJuly 2025 Outlook & Long Hold Capital Preservation Plans - Newser
Is BioAge Labs Inc. (Y7G) stock bottoming after sell off2025 Major Catalysts & Daily Volume Surge Trade Alerts - Newser
BioAge Labs announces positive phase 1 trial results - MSN
Bioage Labs (BIOA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is BioAge Labs Inc. (Y7G) stock supported by free cash flowVolume Spike & Fast Moving Stock Watchlists - Newser
Jefferies Financial Group Inc. Buys Shares of 50,000 BioAge Labs, Inc. $BIOA - MarketBeat
What analysts say about BioAge Labs Inc Y7G stockFibonacci Extensions & Rapid Capital Trading Tips - earlytimes.in
Dhanalaxmi Roto Spinners Limited Stock Analysis Technical Signals for YEARCash Flow Trends & Invest With Confidence - earlytimes.in
BioAge Labs to Present at Piper Sandler 37th Annual Healthcare Conference - Sahm
Recent uptick might appease BioAge Labs, Inc. (NASDAQ:BIOA) institutional owners after losing 55% over the past year - Yahoo Finance
Is BioAge Labs Inc a good long term investmentCapital Gains Strategies & Small Budget Portfolio Growth - earlytimes.in
BioAge stock craters 70% on obesity drug study halt (update) - MSN
Is BioAge Labs Inc. stock recession proofStop Loss & Free Weekly Watchlist of Top Performers - newser.com
Will BioAge Labs Inc. (Y7G) stock hit analyst forecastsBuy Signal & Expert Curated Trade Ideas - newser.com
BioAge Labs (BIOA) Price Target Increased by 20.83% to 9.86 - MSN
Is BioAge Labs Inc. (Y7G) stock a buy on weakness2025 Short Interest & Risk Adjusted Buy and Sell Alerts - newser.com
How interest rate cuts could boost BioAge Labs Inc. stock2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com
Is BioAge Labs Inc. stock a buy before product launchesMarket Volume Report & Weekly Top Stock Performers List - newser.com
1.48%
0.09%
자본화:
|
볼륨(24시간):